Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo.

Li L, Wang Y, Chen J, Cheng B, Hu J, Zhou Y, Gao X, Gao L, Mei X, Sun M, Zhang Z, Song H.

Evid Based Complement Alternat Med. 2013;2013:423129. doi: 10.1155/2013/423129. Epub 2013 May 8.

2.
3.
4.

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.

Lam TL, Wong GK, Chow HY, Chong HC, Chow TL, Kwok SY, Cheng PN, Wheatley DN, Lo WH, Leung YC.

Pigment Cell Melanoma Res. 2011 Apr;24(2):366-76. doi: 10.1111/j.1755-148X.2010.00798.x. Epub 2010 Dec 6.

PMID:
21029397
5.

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.

Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL, Kwok SY, Poon RT, Wheatley DN, Lo WH, Leung YC.

Cancer Lett. 2009 May 8;277(1):91-100. doi: 10.1016/j.canlet.2008.11.031. Epub 2009 Jan 12.

PMID:
19138817
7.

Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.

Tate DJ Jr, Vonderhaar DJ, Caldas YA, Metoyer T, Patterson JR 4th, Aviles DH, Zea AH.

J Hematol Oncol. 2008 Sep 25;1:14. doi: 10.1186/1756-8722-1-14.

8.

Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.

Manca A, Sini MC, Izzo F, Ascierto PA, Tatangelo F, Botti G, Gentilcore G, Capone M, Mozzillo N, Rozzo C, Cossu A, Tanda F, Palmieri G.

Oncol Rep. 2011 Jun;25(6):1495-502. doi: 10.3892/or.2011.1220. Epub 2011 Mar 18.

PMID:
21424129
9.

Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.

Wang M, Basu A, Palm T, Hua J, Youngster S, Hwang L, Liu HC, Li X, Peng P, Zhang Y, Zhao H, Zhang Z, Longley C, Mehlig M, Borowski V, Sai P, Viswanathan M, Jang E, Petti G, Liu S, Yang K, Filpula D.

Bioconjug Chem. 2006 Nov-Dec;17(6):1447-59. Erratum in: Bioconjug Chem. 2007 Mar-Apr;18(2):605.

PMID:
17105223
10.

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.

Kelly MP, Jungbluth AA, Wu BW, Bomalaski J, Old LJ, Ritter G.

Br J Cancer. 2012 Jan 17;106(2):324-32. doi: 10.1038/bjc.2011.524. Epub 2011 Dec 1.

11.

Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma.

Chow AK, Ng L, Sing Li H, Cheng CW, Lam CS, Yau TC, Cheng PN, Fan ST, Poon RT, Pang RW.

Curr Cancer Drug Targets. 2012 Nov 1;12(9):1233-43. Review.

PMID:
22873218
13.

Arginine deiminase, a potential anti-tumor drug.

Ni Y, Schwaneberg U, Sun ZH.

Cancer Lett. 2008 Mar 8;261(1):1-11. doi: 10.1016/j.canlet.2007.11.038. Epub 2008 Jan 7. Review.

PMID:
18179862
14.
15.

Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine.

Bernard A, Kasten M, Meier C, Manning E, Freeman S, Adams W, Chang P, Boulanger B, Kearney P.

Surgery. 2008 Feb;143(2):286-91. doi: 10.1016/j.surg.2007.07.037. Epub 2007 Dec 21.

PMID:
18242346
16.
17.

Regulation of NK cell function by human granulocyte arginase.

Oberlies J, Watzl C, Giese T, Luckner C, Kropf P, Müller I, Ho AD, Munder M.

J Immunol. 2009 May 1;182(9):5259-67. doi: 10.4049/jimmunol.0803523.

18.

Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.

Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA.

Med Sci Monit. 2002 Jul;8(7):BR248-53.

PMID:
12118186
19.

Regression of hepatocellular cancer in a patient treated with arginine deiminase.

Curley SA, Bomalaski JS, Ensor CM, Holtsberg FW, Clark MA.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1214-6.

PMID:
14571701
20.

Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini.

Takaku H, Misawa S, Hayashi H, Miyazaki K.

Jpn J Cancer Res. 1993 Nov;84(11):1195-200.

PMID:
8276724

Supplemental Content

Support Center